US Broker Ratings

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A Biotech Powerhouse with a 16.49% Upside Potential

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the biotechnology sector with its focus on addressing diseases driven by dysregulated aldosterone. With a market capitalization..

Kestra Medical Technologies, Ltd (KMTS) Stock Analysis: A High-Growth Opportunity in Healthcare Innovation

Kestra Medical Technologies, Ltd (KMTS), a promising player in the healthcare sector, has been gaining traction among investors due to its innovative approach in the medical..

Ligand Pharmaceuticals (LGND) Stock Analysis: Unpacking a 14.8% Potential Upside in the Biotech Sector

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is emerging as a compelling player in the biotechnology sector, with a promising 14.8% potential upside according to recent analyst ratings...

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Explosive Growth Potential with 24.64% Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, is catching the attention of investors with its innovative approach to tackling intractable diseases...

Organon & Co. (OGN) Stock Analysis: Navigating a 36.92% Potential Upside Amid Market Challenges

In the dynamic landscape of the healthcare sector, Organon & Co. (NYSE: OGN) stands as a distinctive player, focusing on prescription therapies and medical devices with..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: A Promising 28.66% Upside Potential

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) has been making waves in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring 13.41% Potential Upside in the Healthcare Diagnostics Arena

For investors seeking opportunities within the healthcare sector, NeoGenomics, Inc. (NASDAQ: NEO) presents an intriguing proposition. As a prominent player in the diagnostics and research industry,..

Neogen Corporation (NEOG) Investor Outlook: Potential Upside of 39.36% Amidst Healthcare Sector Challenges

Neogen Corporation (NEOG), a notable player in the healthcare sector within the diagnostics and research industry, presents an intriguing case for investors seeking a blend of..

Guardian Pharmacy Services, Inc (GRDN): Growth Potential with 18.55% Upside

Guardian Pharmacy Services, Inc. (GRDN), a prominent player in the healthcare sector, operates within the medical care facilities industry, focusing on providing specialized pharmacy services to..

Progyny, Inc. (PGNY) Stock Analysis: Unveiling a 10.56% Potential Upside in the Healthcare Plans Sector

Progyny, Inc. (NASDAQ: PGNY) stands as a unique player in the healthcare sector, specifically within the niche of fertility and family-building benefits management. With a market..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring Growth Potential and Analyst Ratings

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has been garnering attention in the biotechnology sector for its focus on addressing unmet medical needs in autoimmune diseases. As a..

Harmony Biosciences Holdings, Inc. (HRMY): A Promising Biotech with a 29% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) has emerged as a notable player in the biotechnology sector, particularly focusing on therapies for rare and neurological diseases. With..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Promising Biotech with 23.88% Potential Upside

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage biotechnology company, has been capturing investor interest with its innovative approach to drug development and a promising pipeline that..

The Pennant Group, Inc. (PNTG) Stock Analysis: Strong Revenue Growth and a 25% Upside Potential

The Pennant Group, Inc. (NASDAQ: PNTG) is gaining traction in the healthcare sector, particularly within the medical care facilities industry. Investors are keeping a keen eye..

Phreesia, Inc. (PHR) Stock Report: Analyzing a Promising 65.50% Upside with Robust Analyst Support

Phreesia, Inc. (PHR) is making waves in the healthcare sector with its innovative software-as-a-service (SaaS) platform aimed at enhancing the efficiency of healthcare processes. As a..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Unveiling Growth Potential in the Biotech Sector

Tarsus Pharmaceuticals, Inc. (TARS) is capturing the attention of investors with its strategic focus on eye care therapeutics, a promising niche within the healthcare sector. As..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Navigating the Biotech Wave with a 46% Potential Upside

As Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) continues to make strides in the biotechnology sector, investors are keenly watching its stock performance, buoyed by a potential upside..

Travere Therapeutics (TVTX) Stock Analysis: Unveiling a 15.95% Potential Upside in the Biotech Arena

Travere Therapeutics, Inc. (NASDAQ: TVTX) is capturing the attention of investors with its remarkable growth story in the dynamic healthcare sector. With a market capitalization of..

BioLife Solutions, Inc. (BLFS) Investor Outlook: Analysts See 21.82% Upside Potential

BioLife Solutions, Inc. (BLFS), a key player in the healthcare sector specializing in medical instruments and supplies, is making a significant mark within the cell and..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Analyzing a 23% Potential Upside in the Biotech Sector

Viridian Therapeutics, Inc. (NASDAQ: VRDN) stands out in the biotechnology industry, not only for its innovative approach to treating serious and rare diseases but also for..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds